title: The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines.
abstract: Hepatitis C virus (HCV) binds to platelets in chronically infected patients where free HCV constitutes only about 5% of total circulating virus. Free HCV preferentially binds to human mononuclear cell lines but free and complexed virus binds equally to platelets. The extent of free HCV binding to human Molt-4 T cells (which express CD81) and to human promonocytic U937 cells or to platelets (which do not express CD81) was similar. The binding of free HCV to the cell lines was saturated at a virus dose of 1 IU HCV RNA per cell but binding to platelets was not saturable. Human anti-HCV IgG, but not anti-CD81, markedly inhibited HCV binding to target cells in a dose-dependent manner. Human antibodies to HCV hypervariable region 1 of E2 glycoprotein partially inhibited viral binding to target cells. Recombinant E2 also inhibited viral binding to target cells in a dose-dependent manner, with the efficacy of this decreasing in the rank order of Molt-4 cells more than U937 cells more than platelets. In contrast to HCV, recombinant E2 bound to Molt-4 cells to an extent markedly greater than that apparent with U937 cells or platelets. These results suggest that the binding of HCV to blood cells is mediated by multiple cell surface receptors and that recombinant E2 binding may not be representative of the interaction of the intact virus with target cells.
authors.affiliation: Division of Transfusion Medicine, Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
authors.forename: S
authors.initials: S
authors.lastname: Hamaia
authors.forename: C
authors.initials: C
authors.lastname: Li
authors.forename: J P
authors.initials: JP
authors.lastname: Allain
mesh_terms: D000914:Antibodies, Viral / Q000502:physiology*; D015703:Antigens, CD / Q000502:physiology; D001792:Blood Platelets / Q000821:virology*; D016174:Hepacivirus / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007938:Leukemia / Q000821:virology*; D007963:Leukocytes, Mononuclear / Q000821:virology*; D008565:Membrane Proteins; D011991:Receptors, Virus / Q000502:physiology*; D011994:Recombinant Proteins / Q000276:immunology; D013601:T-Lymphocytes / Q000821:virology; D060225:Tetraspanin 28; D014407:Tumor Cells, Cultured; D020298:U937 Cells; D014759:Viral Envelope Proteins / Q000235:genetics / Q000276:immunology
chemical_list: D000914:Antibodies, Viral; D015703:Antigens, CD; C554798:CD81 protein, human; D008565:Membrane Proteins; D011991:Receptors, Virus; D011994:Recombinant Proteins; D060225:Tetraspanin 28; D014759:Viral Envelope Proteins; C091015:glycoprotein E2, Hepatitis C virus